ym 529 has been researched along with mevalonic acid in 3 studies
Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (mevalonic acid) | Trials (mevalonic acid) | Recent Studies (post-2010) (mevalonic acid) |
---|---|---|---|---|---|
140 | 23 | 71 | 3,810 | 33 | 922 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iguchi, T; Ikeda, Y; Kizaki, M; Miyakawa, Y; Yamamoto, K | 1 |
Fujiwara, I; Magae, J; Mizuta, M; Mizuta, N; Nakajima, H; Sakaguchi, K; Sawai, K; Tsuruga, M; Yamagishi, H | 1 |
Aoyama, K; Kimoto, A; Minamide, T; Miyata, K; Mori, H; Mori, M; Nozaki, K; Sasamata, M; Shimizu, K; Shimokawa, K; Suzuki, H; Tanaka, M; Usui, T; Yamamotoya, H | 1 |
1 review(s) available for ym 529 and mevalonic acid
Article | Year |
---|---|
Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Geranyltranstransferase; GTP-Binding Proteins; Humans; Imidazoles; Mevalonic Acid; Osteoporosis; Spinal Fractures | 2009 |
2 other study(ies) available for ym 529 and mevalonic acid
Article | Year |
---|---|
Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway.
Topics: Apoptosis; Cell Division; Cell Line, Tumor; Checkpoint Kinase 1; Diphosphonates; Diterpenes; Enzyme Inhibitors; Farnesol; Humans; Imidazoles; Interleukin-6; MAP Kinase Signaling System; Mevalonic Acid; Multiple Myeloma; Phosphorylation; Protein Kinases; S Phase; Signal Transduction; Stromal Cells | 2003 |
Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Breast Neoplasms; Diphosphonates; Drug Screening Assays, Antitumor; Humans; Imidazoles; Mevalonic Acid; Mitochondria; Polyisoprenyl Phosphates; Sesquiterpenes; Signal Transduction | 2007 |